Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Kazuyuki Sogawa

Matched on OpenAlex author ID A5042556610. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Complement Factor B Blockade by Iptacopan Drives Antitumor Complement-Based Immunomodulation in Pancreatic Cancer Microenvironment. Co-author DOI 10.1016/j.ajpath.2026.08.005↗
  2. Serum fucosylated receptor expression-enhancing protein 5 as a biomarker for early stage pancreatic cancer. Co-author DOI 10.3892/ol.2025.15302↗
  3. Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. Co-author DOI 10.1111/cas.15444↗
  4. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
  5. Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.12388↗
  6. Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Co-author DOI 10.1111/cas.13181↗
  7. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Co-author DOI 10.1038/bjc.2016.295↗
  8. The application of a three-step proteome analysis for identification of new biomarkers of pancreatic cancer. Co-author DOI 10.1155/2011/628787↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigetsugu Takano · 8 shared papers, 2011–2026 · strength 1.10
  2. Masayuki Ohtsuka · 6 shared papers, 2016–2026 · strength 1.02
  3. Yoji Miyahara · 3 shared papers, 2021–2022 · strength 0.40
  4. Katsunori Furukawa · 3 shared papers, 2021–2022 · strength 0.40
  5. Fumio Nomura · 5 shared papers, 2011–2021 · strength 0.37
  6. Daren Zhou · 1 shared paper, 2026 · strength 0.32
  7. Takeshi Tomonaga · 2 shared papers, 2011–2025 · strength 0.28
  8. Masaru Miyazaki · 4 shared papers, 2011–2021 · strength 0.24
  9. Mamoru Satoh · 4 shared papers, 2011–2021 · strength 0.24
  10. Hideyuki Yoshitomi · 4 shared papers, 2011–2021 · strength 0.24
  11. Kosuke Sasaki · 2 shared papers, 2021 · strength 0.23
  12. Satoshi Tomizawa · 1 shared paper, 2022 · strength 0.16
  13. Reiri Shimazaki · 1 shared paper, 2021 · strength 0.11
  14. Shingo Kagawa · 1 shared paper, 2021 · strength 0.11
  15. Masayuki Otsuka · 1 shared paper, 2017 · strength 0.06
  16. Osamu Yokosuka · 1 shared paper, 2016 · strength 0.05
  17. Rintaro Mikata · 1 shared paper, 2016 · strength 0.05
  18. Mayinuer Abulaizi · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.